Sources

8 Total Sources

U.S. Exempts Generic Drugs From 100% Pharma Tariffs as India Supplies 40% of Prescriptions

Left67%
Center33%
The New York Times2h ago
US Domestic Generic Drug Production Challenged by India's Low-Cost Manufacturing
usthadian.com2h ago
Rare Disease Drugs and India's Emerging Pharmaceutical Opportunity - Current Affairs Usthadian Academy
drugpatentwatch.com2h ago
Branded Generics and Why They're Profitable - DrugPatentWatch – Transform Data into Market Domination
rkenterpriseindia.com2h ago
When Every Week Counts: How Indian Process Engineers Are Closing the Gap in American Manufacturing — RKN Enterprise India
The New York Times2h ago
This Closed Factory Shows How Hard Reviving Drug Manufacturing Will Be - The New York Times
Facebook2h ago
US pharma tariff relief reshapes risks for Indian drugmakers. Read how Sun Pharma, Gland Pharma, Zydus and others are affected. READ HERE: https://www.financialexpress.com/market/us-pharma-tariff-rel
biopharmaapac.com2h ago
Piramal and NP2 Advance Generic Cancer Drug Cyclophosphamide Towards US Manufacturing
Healthcare Dive2h ago
The Trump administration wants to onshore drug manufacturing. Technologists are answering the call. | Healthcare Dive